About Vascular Pathways
Vascular Pathways is a company based in Naples (United States) founded in 2005 was acquired by CR Bard in June 2014. Vascular Pathways has raised $19.53 million across 3 funding rounds from investors including Square 1 Bank, CR Bard and CHL Medical Partners. The company has 8 employees. Vascular Pathways operates in a competitive market with competitors including TISSIUM, Laminate Medical, Vivasure Medical, Cardival Medical and Saranas, among others.
- Headquarter Naples, United States
- Employees 8
- SectorsHealthcare
- Website vascularpathways.com
- Social LinkedIn Facebook
- Acquired by CR Bard (Jun 2014)
- Total Equity Funding$19.53M (USD)
in 3 rounds
- Latest Funding Round$5M (USD), Debt – Conventional
Jun 2014
- InvestorsSquare 1 Bank
& 2 more
- Employee Count8
- Acquired byCR Bard
(Jun 2014)
Funding Insights of Vascular Pathways
Vascular Pathways has successfully raised a total of $19.53M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $5 million completed in June 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $19.53M
- Total Rounds 3
- Last Round Debt – Conventional — $5M
- First Round $14M
(May 2012)
- Investors Count 2
All 3 funding rounds of Vascular Pathways with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2014 | $5M | Debt – Conventional | – | – | |
| May 2014 | $5.53M | Series B | – | – | – |
| May 2012 | $14M | Series B | – | CHL Medical Partners | – |
3 investors in total: 3 institutional.
Investors in Vascular Pathways
Vascular Pathways has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Square 1 Bank, CR Bard and CHL Medical Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early stage healthcare services investments are facilitated by CHL. | – | chlmedical.com | Westport, United States | |
Venture debt, treasury, and cash management services are provided. | 2005 | square1bank.com | Durham, United States | |
Products for vascular, urology, oncology, and surgical specialties | 1907 | crbard.com | Murray, United States |
Investor details for Vascular Pathways
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Vascular Pathways
1 people are tracked at Vascular Pathways (1 in leadership); the tracked headcount is 8.
| Name | Role | Group |
|---|---|---|
Gene Starr | CEO | Leadership |
Complete people profiles for Vascular Pathways
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Vascular Pathways
4 dated milestones of Vascular Pathways across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Vascular Pathways is founded.
- Funding First funding round of $14.0M.
- Funding Latest funding round, Debt – Conventional, of $5.0M.
- Exit Acquired by CR Bard.
Competitors of Vascular Pathways
Vascular Pathways operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TISSIUM, Laminate Medical, Vivasure Medical, Cardival Medical and Saranas, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tissium.com | 2013 | Paris, France | $155.98M | – | Vascular sealants for open surgery are developed by TISSIUM. | |
| laminatemedical.com | 2012 | Rehovot, Israel | $20M | – | AV fistula maturation and patency are supported by VasQ device. | |
| vivasuremedical.com | 2009 | Galway, Ireland | $92.08M | – | Bioabsorbable implants and delivery systems for arteriotomy closure are developed. | |
| cardivamedical.com | 2002 | Santa Clara, United States | $169.45M | 158 | A device for vascular access management is developed. | |
| saranas.com | 2011 | Houston, United States | $29.46M | – | A device is developed for detecting internal bleeding during catheterization. | |
| aziyo.com | 2015 | Silver Spring, United States | $49.59M | 162 | Regenerative medicine products are developed for orthopedic and cardiovascular applications. | |
| cordis.com | 1957 | Fremont, United States | – | 5 | Cardiovascular and endovascular devices are developed and marketed by Cordis. | |
| innavasc.com | 2013 | Durham, United States | $3.34M | – | Synthetic vascular grafts with self-sealing chambers for hemodialysis are developed. | |
| ekoscorp.com | 1995 | Bothell, United States | $58.8M | – | Ultrasound thrombolytic devices for pulmonary embolism treatment are developed. | |
| figure8surgical.com | 2009 | Palo Alto, United States | $43.1M | – | Offers a sternal closure system designed for open-heart surgery patients. |
Detailed competitors of Vascular Pathways
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vascular Pathways
Complete news archive for Vascular Pathways
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Vascular Pathways
10 companies that operate in the same segment as Vascular Pathways (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vascular Pathways
Vascular Pathways was founded in 2005 and raised its 1st funding round 7 years after it was founded.
Vascular Pathways is headquartered in Naples, United States. It is registered at Naples, Florida, United States.
Gene Starr is the current CEO of Vascular Pathways.
Vascular Pathways is a funded company, having raised a total of $19.53M across 3 funding rounds to date. The company's 1st funding round was a Series B of $14M, raised on May 2012.
Vascular Pathways has 8 employees.
Vascular Pathways was founded in 2005 in Naples, United States, within the medical devices sector focused on vascular access. Devices such as the AccuCath Intravenous Catheters, which incorporate Nitinol guidewire technology, are developed for blood sampling, pressure monitoring, and intravenous fluid administration in peripheral IV scenarios. Operations include commercialization of these FDA-approved products. Since July 1, 2015, the company has operated as a subsidiary of CR Bard.
Vascular Pathways's top competitors include TISSIUM, Vivasure Medical and Cardival Medical.
Vascular Pathways has 3 investors. Key investors include Square 1 Bank, CR Bard, and CHL Medical Partners.
Yes. Vascular Pathways was acquired by CR Bard in June 2014.